Cellebrite DI officer plans $110K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cellebrite DI Ltd. (CLBT) officer Marcus Jewell reported a planned sale of 9,928 common shares, with an aggregate market value of $110,399.36 and an approximate sale date of November 17, 2026. The shares were acquired upon vesting of restricted stock units from August 11 through November 15, 2026; the notice lists August 14, 2026, as the Rule 10b5-1 plan adoption or instruction date.
Key Figures
Key Terms
restricted stock units financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.